Esta es la version de las 3.30 pm del 24 de junio del 2010 del proyecto de conclusiones de la OMPI SCCR 20 en espanol. El documento fue distribuido durante el dia de hoy por el secretariado de la OMPI y esta siendo discutido. Este texto va a ser negociado esta tarde.

Organización Mundial de la Propiedad Intelectual
Comité de Derecho de Autor y Derechos Conexos (SCCR)
Vigésima sesión
Ginebra, 21 a 24 de junio de 2010

Proyecto de conclusiones

PROTECCIÓN DE LOS ORGANISMOS DE RADIODIFUSIÓN

In briefings about the WIPO proposal for a treaty for persons who are blind or have other disabilities, the U.S. government has sent mixed signals regarding the legality of exporting of accessible works created under exceptions in U.S. law. In some informal briefings and conversations, the U.S. government has said such exports are allowed under U.S. law. At other times, they say they are not.

KEI has obtained a June 12, 2008 memo from the U.S. Copyright Office, written by Neil Conley to David Carson, that analyzes the possible extraterritorial effects of the Chafee Amendment.

On June 7, 2010 medicine access advocacy groups joined together in asking that George Washington University (GWU) put a stop to its industry-sponsored intellectual property (IP) summits and to take an academic, evidenced-based approach to conferences it conducts in India.

The ties between Universities and businesses are often complex and blurred. Private companies or trade associations fund research and seminars, and have consulting relationships with faculty members, trying to shape public policy and judicial decisions on a wide range of issues. A particularly interesting industry/university connection concerns something called the "India Project," that is associated with the George Washington University (GWU) Law School.

On February 18, 2010, 12 NGOs working on Access to Medicines submitted joint comments to the 2010 Special 301 Process

The submission is available here.

And a summary below:

SUBMISSION OF GLOBAL HEALTH ORGANIZATIONS:

La Organización Nacional de Ciegos de España (ONCE) agradece la oportunidad que nos ha brindado de tomar la palabra en esta importante sesion del SCCR para pedir el apoyo a la propuesta de tratado de la Union Mundial de Ciegos, organización de la que la ONCE es miembro.

La ONCE da servicio exclusivo a sus afiliados, que han de ser personas ciegas y deficientes visuales con nacionalidad española. Actualmente la ONCE tiene 70000 afiliados, y su número crece en 4000 cada año.

Information for the SCCR at WIPO 14-18 December, 2009.

Mr Chairman,

I would like to take this opportunity, in the framework of our discussions on exceptions and limitations, to inform you about what the European Commission has been doing over the past year and a half and is preparing for the future.

We are distributing this letter (in English and Spanish, with Tiflolibros Argentina) to writers, journalists and authors who support the World Blind Union WIPO treaty proposal to improve access to books in formats accessible to people who are blind, visually impaired or have other disabilities. If you are a writer and you are interested in signing it, contact judit.rius@keionline.org

On November 23, 2009, Pablo Lecuona from Tiflolibros Argentina sent a letter to Kareem A. Dale, the Special Assistant to the President for Disability Policy, asking the Obama Administration to support the WIPO Copyright treaty for the blind, visually impaired and people with reading disabilities. Mr. Lecuona has also submitted this letter to the U.S. Copyright Office, and the USPTO as a reply in the request for comments on the WIPO Treaty proposal. Among other things, the Tifloibros letter says:

Korean civil society has asked KEI to disseminate this request for solidarity and action in their efforts to reduce the price of Gleevec, a leukemia treatment pill. The current price is approximately 2,300 USD per month for an adult patient and the Korean government has been sued by Novartis for trying to reduce the price a 14%. Korean civil society is also requesting Novartis to introduce a higher form, 400 mg, in Korea.

REQUEST for Solidarity: